Format

Send to

Choose Destination
Trends Mol Med. 2001 Aug;7(8):350-4.

Yellow fever vector live-virus vaccines: West Nile virus vaccine development.

Author information

1
Acambis Inc. 38 Sidney Street, Cambridge, MA 02319, USA. juan.arroyo@acambis.com

Abstract

By combining molecular-biological techniques with our increased understanding of the effect of gene sequence modification on viral function, yellow fever 17D, a positive-strand RNA virus vaccine, has been manipulated to induce a protective immune response against viruses of the same family (e.g. Japanese encephalitis and dengue viruses). Triggered by the emergence of West Nile virus infections in the New World afflicting humans, horses and birds, the success of this recombinant technology has prompted the rapid development of a live-virus attenuated candidate vaccine against West Nile virus.

PMID:
11516995
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center